We are live on ! Find out more
State of Wisconsin Investment Board

State of Wisconsin Investment Board Portfolio holdings

AUM $43.7B
1-Year Est. Return 27.76%
This Fund
S&P 500
This Quarter Est. Return
+7.52%
1 Year Est. Return
+27.76%
3 Year Est. Return
+95.56%
5 Year Est. Return
+123.77%
10 Year Est. Return
+486.44%
AUM
$36.2B
AUM Growth
+$1.42B
Cap. Flow
-$709M
Cap. Flow %
-1.96%
Top 10 Hldgs %
17.17%
Holding
1,578
New
109
Increased
327
Reduced
821
Closed
39

Sector Composition

Rank Sector Weight
1 Technology 18.08%
2 Financials 15.98%
3 Healthcare 13.44%
4 Consumer Discretionary 10.15%
5 Industrials 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LRMR icon
1476
Larimar Therapeutics
LRMR
$454M
$277K ﹤0.01%
+1,975
New +$240K
MNKD icon
1477
MannKind Corp
MNKD
$1.24B
$268K ﹤0.01%
+146,600
New +$225K
MCY icon
1478
Mercury Insurance
MCY
$5.84B
$267K ﹤0.01%
5,316
DOVA
1479
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$258K ﹤0.01%
+12,300
New +$293K
CNA icon
1480
CNA Financial
CNA
$13.7B
$251K ﹤0.01%
5,501
QTTB icon
1481
Q32 Bio
QTTB
$458M
$247K ﹤0.01%
+600
New +$204K
XOG
1482
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
$244K ﹤0.01%
21,634
ABEO icon
1483
Abeona Therapeutics
ABEO
$425M
$243K ﹤0.01%
760
ALDX icon
1484
Aldeyra Therapeutics
ALDX
$91.7M
$243K ﹤0.01%
+17,600
New +$143K
CASI
1485
DELISTED
CASI Pharmaceuticals
CASI
$243K ﹤0.01%
+5,200
New +$363K
CRBP icon
1486
Corbus Pharmaceuticals
CRBP
$189M
$242K ﹤0.01%
1,067
KDMN
1487
DELISTED
Kadmon Holdings, Inc.
KDMN
$242K ﹤0.01%
+72,400
New +$257K
CCXI
1488
DELISTED
ChemoCentryx, Inc.
CCXI
$240K ﹤0.01%
19,000
SNNA
1489
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$239K ﹤0.01%
+16,100
New +$256K
TTOO
1490
DELISTED
T2 Biosystems, Inc
TTOO
$238K ﹤0.01%
+6
New +$198K
BSTC
1491
DELISTED
BioSpecifics Technologies Corp.
BSTC
$234K ﹤0.01%
+4,000
New +$204K
CRD.B icon
1492
Crawford & Co Class B
CRD.B
$589M
$230K ﹤0.01%
+25,000
New +$218K
SYBX
1493
DELISTED
Synlogic
SYBX
$229K ﹤0.01%
+1,073
New +$170K
NERV icon
1494
Minerva Neurosciences
NERV
$187M
$226K ﹤0.01%
2,250
EAF icon
1495
GrafTech
EAF
$201M
$223K ﹤0.01%
+1,145
New +$216K
CBMG
1496
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$218K ﹤0.01%
+12,100
New +$248K
KERX
1497
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$207K ﹤0.01%
61,000
OPTN
1498
DELISTED
OptiNose
OPTN
$206K ﹤0.01%
1,107
CPRX
1499
DELISTED
Catalyst Pharmaceutical
CPRX
$204K ﹤0.01%
54,000
PTN
1500
Palatin Technologies
PTN
$16.8M
$204K ﹤0.01%
+164
New +$203K

Similar funds

State of Wisconsin Investment Board's Q3 2018 Portfolio in Review

As of Q3 2018, State of Wisconsin Investment Board held 1,578 positions worth $36.2B, up 4.1% from $34.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

State of Wisconsin Investment Board's Q3 2018 filing shows 109 new, 327 increased, 821 reduced and 39 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 379,270 shares worth $24.3M. The largest sale was Royal Dutch Shell PLC ADS Class A, an estimated $111M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • State of Wisconsin Investment Board's largest Q3 2018 buy was iShares Core MSCI EAFE ETF: 379,270 shares worth $24.3M.
  • State of Wisconsin Investment Board added most to iShares Core MSCI Emerging Markets ETF in Q3 2018, an estimated $157M increase.
  • State of Wisconsin Investment Board's biggest Q3 2018 reduction was Royal Dutch Shell PLC ADS Class A, cutting an estimated $111M.
  • State of Wisconsin Investment Board fully exited iShares Core S&P 500 ETF in Q3 2018, selling an estimated $48.3M.
  • State of Wisconsin Investment Board's ten largest holdings make up 17% of its $36.2B portfolio in Q3 2018.
  • State of Wisconsin Investment Board opened 109 new positions and closed 39 in Q3 2018.
  • State of Wisconsin Investment Board's portfolio value rose 4.1% quarter-over-quarter to $36.2B.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2018, filed 14 Nov 2018.